Clinical Safety

Atrogi intends to launch the next phase of clinical trials in 2027 to establish a definitive proof of concept across a larger and more diverse demographic of patients. For decades, the pharmaceutical industry has searched for a "holy grail" that could fundamentally alter human body composition by

The traditional 'take-make-waste' model of medical manufacturing is being challenged by researchers who view the environmental footprint of healthcare as a critical engineering problem. For decades, the medical industry has operated under a strict mandate of patient safety and clinical sterility, a

Genomic literacy is not evenly distributed across the population, with significant disparities in awareness based on religion, education, and ancestral background. This observation serves as a cornerstone for Singapore’s latest health initiative, which shifts the focus of genetic medicine toward

Biofilms formed by Staphylococcus aureus and Pseudomonas aeruginosa render standard antibiotics ineffective in treating deep dermatological trauma. This biological reality has pushed the field of regenerative medicine toward a major paradigm shift, where the focus has moved away from mere wound

Secrecy surrounding high-level biodefense facilities complicates global health security by hindering the international cooperation necessary to contain emerging laboratory-acquired infections. The recent death of Darya Shipilova, a 28-year-old laboratory worker at the Anti-plague Research Institute

Doctors emphasize the importance of patient transparency regarding peptide use to prevent potential drug interactions and to monitor for any adverse physiological reactions. This chemical sequence, known formally as Body Protection Compound 157, has transcended its origins in laboratory research to